Radiopharmaceutical dosimetry (RD) is an integral part of nuclear imaging and therapy, but current standards for documenting and reporting compound travel patterns inside the human body—biodistribution—in dosimetry-related studies do not exist.

Monitoring cerebrospinal fluid (CSF) biomarkers and imaging for genetic mediators of brain injuries in children may help identify those at risk for abnormal brain development, according to a study published in the Journal of the American Medical Association.

By 2030, some 3.5 million Americans are expected to be living with total knee replacements. The price of performing total-knee arthroplasty (TKA) revision surgery continues to rise, costing 60 percent more than the initial replacement. Researchers set out to identify a more cost-effective method.

A new molecular technique using modified diamonds could increase the sensitivity of an MRI and improve patient diagnosis, according to a University of Melbourne press release.

A new multimodal imaging approach produced highly-advanced molecular three-dimensional (3D) images of staph infection and may be instrumental in fighting antibiotic resistant infections, according to research published in Science Translational Medicine.

TUCSON, Ariz., June 23, 2016 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments and reagents for molecular profiling applications, today announced the introduction of its Tucson‑based VERI/O laboratory service, offering laboratory support for its biopharma clients in biomarker research and companion diagnostic development.  The VERI/O laboratory service formalizes and expands HTG’s traditional service offerings, including molecular profiling of retrospective cohorts to support development of targeted and immuno-oncology therapies, building custom research-use-only (RUO) assays to support early stage clinical programs, and developing companion diagnostic assays for use in Phase III registration trials.

MR Solutions, which introduced cryogen-free MRI scanners in 2012, is now offering a choice of two cryogen-free preclinical scanner ranges – the Flexiscan and Powerscan. The Flexiscan range is available with multi-modality accessories which can be mixed and matched according to research requirements. It is a flexible MRI system as it can incorporate integrated multi-modality options such as PET or SPECT. The Flexiscan system requires no specialist knowledge and can be operated simply by running pre-defined settings. There is no need to materially alter the parameters of the machine.

The repeated impacts experienced in one season of playing high school football can do significant damage to an athlete’s brain, according to a recent study published by the Journal of Neurotrauma.